Regular Treatment With Aspirin 300 mg/day After Desensitization in Patients With N-ERD: 12-Year Results
- 15 October 2021
- journal article
- research article
- Published by AVES YAYINCILIK A.Ş. in Turkish Thoracic Journal/Türk Toraks Dergisi
- Vol. 22 (5), 376-380
- https://doi.org/10.5152/turkthoracj.2021.0298
Abstract
Aspirin desensitization,asthma,endoscopic sinus surgery,nasal polyp,NSAID hypersensitivityKeywords
This publication has 22 references indexed in Scilit:
- Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory diseaseJournal of Allergy and Clinical Immunology, 2014
- Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory diseaseAllergy, 2013
- Non-steroidal anti-inflammatory drug hypersensitivity in adults and the factors associated with asthmaRespiratory Medicine, 2013
- Rhinosinusitis and Aspirin-Exacerbated Respiratory DiseaseJournal of Allergy, 2012
- Long‐term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin dailyAllergy, 2008
- Aspirin-Exacerbated AsthmaAllergy, Asthma & Clinical Immunology, 2008
- Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paperAnnals of Allergy, Asthma & Immunology, 2007
- Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory diseaseJournal of Allergy and Clinical Immunology, 2007
- Systematic review of prevalence of aspirin induced asthma and its implications for clinical practiceBMJ, 2004
- Occurrence of allergic conditions in asthmatics with analgesic intoleranceAllergy, 1999